These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 12959189)

  • 1. GnRH agonist therapy in a patient with recurrent ovarian granulosa cell tumors.
    Kim HJ; Lee SC; Bae SB; Kwon KW; Kim CK; Lee NS; Lee KT; Won JH; Hong DS; Park HS
    J Korean Med Sci; 2009 Jun; 24(3):535-8. PubMed ID: 19543423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-hormonal interruption of incessant ovulation as a potential approach for ovarian cancer prevention.
    Fathalla MF
    Int J Gynaecol Obstet; 2016 Mar; 132(3):356-8. PubMed ID: 26876699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progestin-induced apoptosis in the Macaque ovarian epithelium: differential regulation of transforming growth factor-beta.
    Rodriguez GC; Nagarsheth NP; Lee KL; Bentley RC; Walmer DK; Cline M; Whitaker RS; Isner P; Berchuck A; Dodge RK; Hughes CL
    J Natl Cancer Inst; 2002 Jan; 94(1):50-60. PubMed ID: 11773282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention of ovarian cancer.
    Hoekstra A; Rodriguez GC
    Cancer Treat Res; 2009; 149():3-34. PubMed ID: 19763429
    [No Abstract]   [Full Text] [Related]  

  • 5. Noncontraceptive health benefits of oral steroidal contraceptives.
    Mishell DR
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):809-16. PubMed ID: 7065059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of progestin on the ovarian epithelium of macaques: cancer prevention through apoptosis?
    Rodriguez GC; Walmer DK; Cline M; Krigman H; Lessey BA; Whitaker RS; Dodge R; Hughes CL
    J Soc Gynecol Investig; 1998; 5(5):271-6. PubMed ID: 9773403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights regarding pharmacologic approaches for ovarian cancer prevention.
    Rodriguez G
    Hematol Oncol Clin North Am; 2003 Aug; 17(4):1007-20, x. PubMed ID: 12959189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible role of ovarian epithelial inflammation in ovarian cancer.
    Ness RB; Cottreau C
    J Natl Cancer Inst; 1999 Sep; 91(17):1459-67. PubMed ID: 10469746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-kappaB, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen- and NSAID-prevention of the ovarian cancer.
    Altinoz MA; Korkmaz R
    Neoplasma; 2004; 51(4):239-47. PubMed ID: 15254653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradigms for primary prevention of ovarian carcinoma.
    Barnes MN; Grizzle WE; Grubbs CJ; Partridge EE
    CA Cancer J Clin; 2002; 52(4):216-25. PubMed ID: 12139233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence.
    Riman T; Persson I; Nilsson S
    Clin Endocrinol (Oxf); 1998 Dec; 49(6):695-707. PubMed ID: 10209555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of reproductive hormones in epithelial ovarian carcinogenesis.
    Gharwan H; Bunch KP; Annunziata CM
    Endocr Relat Cancer; 2015 Dec; 22(6):R339-63. PubMed ID: 26373571
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.